Glycosylated Peptide Market Report

Global and Region Glycosylated Peptide Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：232
  • REPORT CODE：GMM1021898
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Peptide glycosylation is a covalent modification that can potentially improve the physicochemical properties of peptides.

    Some advantages of glycosylated peptides include: (1) increased bioavailability, (2) increased metabolic stability, (2) targeting specific tissues and organs, (3) reduction in clearance rates, (4) enhanced receptor binding, (5) facilitation of active transport across cell membranes (glucose transporters), and (6) maintaining the overall physical properties of peptides (precipitation, aggregation, thermal and kinetic denaturation).Glycopeptides are recognized as peptides that contain glycans (carbohydrate molecules) and can be generalized classified into three types based on the linkage or bond type between the amino acid and the glycan: (1) C-linked, (2) O-linked, and (3) N-linked.The most common type in eukaryotic cells is N-linked glycopeptides, noted by the C-N bond from the side chain of asparagine (Asn/N) amino acid. O-Type glycopeptides are named after the C-O bond from the side chains of serine (Ser) and threonine (Thr) amino acids. The least common C-linked types are recognized as the bond between a tryptophan residue and the sugar mannose.

    The report details the trend, potential and market size of Glycosylated Peptide market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Glycosylated Peptidemarket, defines the market attractiveness level of Glycosylated Peptide market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Glycosylated Peptide industry, describes the types of Glycosylated Peptide market, the applications of major players and the market size, and deeply analyzes the current situation of the global Glycosylated Peptide market and the development prospects and opportunities of Glycosylated Peptide industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Glycosylated Peptide market in Chapter 13.

    By Player:

    • Medtronic

    • Roche

    • Pfizer

    • DrReddys Laboratories

    • Teva Pharmaceuticals Industries

    • Cipla

    • Sandoz International

    • Celltrion

    • Biocon

    • Bachem Americas

    By Type:

    • Monoclonal Antibodies (MABs)

    • Erythropoietin (EPO)

    • Others

    By End-User:

    • Oncology

    • Blood Disorder

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Glycosylated Peptide Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Glycosylated Peptide Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Glycosylated Peptide Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Glycosylated Peptide Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Glycosylated Peptide Market Analysis and Outlook to 2022

    • 7.1 Global Glycosylated Peptide Consumption (2017-2022)

    • 7.2 United States Glycosylated Peptide Consumption (2017-2022)

    • 7.3 Europe Glycosylated Peptide Consumption (2017-2022)

    • 7.4 China Glycosylated Peptide Consumption (2017-2022)

    • 7.5 Japan Glycosylated Peptide Consumption (2017-2022)

    • 7.6 India Glycosylated Peptide Consumption (2017-2022)

    • 7.7 South Korea Glycosylated Peptide Consumption (2017-2022)

    8 Region and Country-wise Glycosylated Peptide Market Analysis and Outlook to 2028

    • 8.1 Global Glycosylated Peptide Consumption Forecast (2022-2028)

    • 8.2 United States Glycosylated Peptide Consumption Forecast (2022-2028)

    • 8.3 Europe Glycosylated Peptide Consumption Forecast (2022-2028)

    • 8.4 China Glycosylated Peptide Consumption Forecast (2022-2028)

    • 8.5 Japan Glycosylated Peptide Consumption Forecast (2022-2028)

    • 8.6 India Glycosylated Peptide Consumption Forecast (2022-2028)

    • 8.7 South Korea Glycosylated Peptide Consumption Forecast (2022-2028)

    9 Global Glycosylated Peptide Market Outlook by Types and Applications to 2022

    • 9.1 Global Glycosylated Peptide Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Monoclonal Antibodies (MABs) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Erythropoietin (EPO) Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Glycosylated Peptide Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Blood Disorder Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Glycosylated Peptide Market Outlook by Types and Applications to 2028

    • 10.1 Global Glycosylated Peptide Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Monoclonal Antibodies (MABs) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Erythropoietin (EPO) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Glycosylated Peptide Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Blood Disorder Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Glycosylated Peptide Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Glycosylated Peptide Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Glycosylated Peptide Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Glycosylated Peptide Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Glycosylated Peptide Market Competitive Analysis

    • 14.1 Medtronic

      • 14.1.1 Medtronic Company Details

      • 14.1.2 Medtronic Glycosylated Peptide Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Medtronic Glycosylated Peptide Product and Service

    • 14.2 Roche

      • 14.2.1 Roche Company Details

      • 14.2.2 Roche Glycosylated Peptide Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Roche Glycosylated Peptide Product and Service

    • 14.3 Pfizer

      • 14.3.1 Pfizer Company Details

      • 14.3.2 Pfizer Glycosylated Peptide Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Pfizer Glycosylated Peptide Product and Service

    • 14.4 DrReddys Laboratories

      • 14.4.1 DrReddys Laboratories Company Details

      • 14.4.2 DrReddys Laboratories Glycosylated Peptide Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 DrReddys Laboratories Glycosylated Peptide Product and Service

    • 14.5 Teva Pharmaceuticals Industries

      • 14.5.1 Teva Pharmaceuticals Industries Company Details

      • 14.5.2 Teva Pharmaceuticals Industries Glycosylated Peptide Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Teva Pharmaceuticals Industries Glycosylated Peptide Product and Service

    • 14.6 Cipla

      • 14.6.1 Cipla Company Details

      • 14.6.2 Cipla Glycosylated Peptide Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Cipla Glycosylated Peptide Product and Service

    • 14.7 Sandoz International

      • 14.7.1 Sandoz International Company Details

      • 14.7.2 Sandoz International Glycosylated Peptide Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Sandoz International Glycosylated Peptide Product and Service

    • 14.8 Celltrion

      • 14.8.1 Celltrion Company Details

      • 14.8.2 Celltrion Glycosylated Peptide Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Celltrion Glycosylated Peptide Product and Service

    • 14.9 Biocon

      • 14.9.1 Biocon Company Details

      • 14.9.2 Biocon Glycosylated Peptide Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Biocon Glycosylated Peptide Product and Service

    • 14.10 Bachem Americas

      • 14.10.1 Bachem Americas Company Details

      • 14.10.2 Bachem Americas Glycosylated Peptide Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Bachem Americas Glycosylated Peptide Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Glycosylated Peptide

    • Figure Glycosylated Peptide Picture

    • Table Global Glycosylated Peptide Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Glycosylated Peptide Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Glycosylated Peptide Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Glycosylated Peptide Consumption by Country (2017-2022)

    • Figure United States Glycosylated Peptide Consumption and Growth Rate (2017-2022)

    • Table Europe Glycosylated Peptide Consumption and Growth Rate (2017-2022)

    • Figure China Glycosylated Peptide Consumption and Growth Rate (2017-2022)

    • Figure Japan Glycosylated Peptide Consumption and Growth Rate (2017-2022)

    • Figure India Glycosylated Peptide Consumption and Growth Rate (2017-2022)

    • Figure South Korea Glycosylated Peptide Consumption and Growth Rate (2017-2022)

    • Figure Global Glycosylated Peptide Consumption Forecast by Country (2022-2028)

    • Figure United States Glycosylated Peptide Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Glycosylated Peptide Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Glycosylated Peptide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Glycosylated Peptide Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Glycosylated Peptide Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Glycosylated Peptide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Monoclonal Antibodies (MABs) Consumption and Growth Rate (2017-2022)

    • Figure Global Erythropoietin (EPO) Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Disorder Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Monoclonal Antibodies (MABs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Erythropoietin (EPO) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Disorder Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Glycosylated Peptide Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Glycosylated Peptide Export by Region (Top 5 Countries) (2017-2028)

    • Table Medtronic (Foundation Year, Company Profile and etc.)

    • Table Medtronic Glycosylated Peptide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic Glycosylated Peptide Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Glycosylated Peptide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Glycosylated Peptide Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Glycosylated Peptide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Glycosylated Peptide Product and Service

    • Table DrReddys Laboratories (Foundation Year, Company Profile and etc.)

    • Table DrReddys Laboratories Glycosylated Peptide Sales, Price, Value and Gross Profit (2017-2022)

    • Table DrReddys Laboratories Glycosylated Peptide Product and Service

    • Table Teva Pharmaceuticals Industries (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceuticals Industries Glycosylated Peptide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceuticals Industries Glycosylated Peptide Product and Service

    • Table Cipla (Foundation Year, Company Profile and etc.)

    • Table Cipla Glycosylated Peptide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cipla Glycosylated Peptide Product and Service

    • Table Sandoz International (Foundation Year, Company Profile and etc.)

    • Table Sandoz International Glycosylated Peptide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sandoz International Glycosylated Peptide Product and Service

    • Table Celltrion (Foundation Year, Company Profile and etc.)

    • Table Celltrion Glycosylated Peptide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celltrion Glycosylated Peptide Product and Service

    • Table Biocon (Foundation Year, Company Profile and etc.)

    • Table Biocon Glycosylated Peptide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biocon Glycosylated Peptide Product and Service

    • Table Bachem Americas (Foundation Year, Company Profile and etc.)

    • Table Bachem Americas Glycosylated Peptide Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bachem Americas Glycosylated Peptide Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US